Select for export Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2016.10.026 PubMed 27810345 Copy citation Copy BibTeX Unknown journal 2016-10-30 Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. Europe PMC Published psilocybin Brain ImagingReceptor PharmacologyDefault Mode Network Systematic Review More
Select for export Role of psilocybin in the treatment of depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316676092 PubMed 28101325 Copy citation Copy BibTeX Therapeutic Advances in Psychopharmacology 2016-10-26 Mahapatra A, Gupta R. Europe PMC Published psilocybin DepressionAnxietyReceptor Pharmacology Other More
Select for export Psilocybin for treating substance use disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14737175.2016.1220834 PubMed 27684102 Copy citation Copy BibTeX Unknown journal 2016-08-11 de Veen BT, Schellekens AF, Verheij MM, Homberg JR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Clinical Trial More
Select for export Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3928/02793695-20160616-09 PubMed 27362381 Copy citation Copy BibTeX Journal of Psychosocial Nursing and Mental Health Services 2016-06-30 Howland RH. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.14704/nq.2016.14.2.943 Copy citation Copy BibTeX NeuroQuantology 2016-05-23 Joseph A. Zamaria OpenAlex Published psilocybin DepressionAnxietyOCD Other More
Select for export Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1124/pr.115.011478 PubMed 26841800 Copy citation Copy BibTeX Unknown journal 2016-03-31 Nichols DE. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316638008 PubMed 27354908 Copy citation Copy BibTeX Unknown journal 2016-03-17 Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2016.01.005 PubMed 26875114 Copy citation Copy BibTeX European Neuropsychopharmacology 2016-01-21 Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessHealthy Volunteers Other More
Select for export The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nicl.2015.08.009 PubMed 26909323 Copy citation Copy BibTeX NeuroImage Clinical 2015-08-21 Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin AnxietyBrain ImagingMechanism of Action Other More
Select for export The hallucinogenic world of tryptamines: an updated review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00204-015-1513-x PubMed 25877327 Copy citation Copy BibTeX Unknown journal 2015-04-15 Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyReview Article Review Article More
Select for export 5HT2a Receptors - a New Target for Depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(15)30027-4 Copy citation Copy BibTeX European Psychiatry 2015-02-28 D.J. Nutt OpenAlex Published psilocybin DepressionReceptor PharmacologyDefault Mode Network Other More
Select for export 14C-Psilocin tissue distribution in pregnant rats after intravenous administration Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31989/ffhd.v4i6.9 Copy citation Copy BibTeX Functional Foods in Health and Disease 2014-07-26 Law Francis, Poon Grace, Chui Y. C., He Shao-Xiong Crossref Published psilocybinpsilocin End-of-Life DistressAnimal Study Animal Study More
Select for export Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2014.04.010 PubMed 24882567 Copy citation Copy BibTeX Biological Psychiatry 2014-04-25 Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Clinical Trial More
Select for export PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A2014 REPORT Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2013-12-31 Robert L. Jesse, Roland R. Griffi OpenAlex Published psilocybin AddictionWellbeingSpirituality Observational Study More
Select for export A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1874473708666150107120930 PubMed 25563444 Copy citation Copy BibTeX Current Drug Abuse Reviews 2013-12-31 Turton S, Nutt DJ, Carhart-Harris RL. Europe PMC Published psilocybin Brain ImagingAgingSpirituality Qualitative Study More
Select for export Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1503/jpn.120128 Copy citation Copy BibTeX Фундаментальные исследования (Fundamental Research) 2013-02-28 Young SN. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/j.1468-5906.2012.01685.x PubMed 23316089 Copy citation Copy BibTeX Journal for the Scientific Study of Religion 2012-11-30 Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. Europe PMC Published psilocybin SpiritualityMystical Experience Other More
Select for export Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2012.04.005 PubMed 22578254 Copy citation Copy BibTeX Biological Psychiatry 2012-05-09 Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Prediction of psilocybin response in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0030800 PubMed 22363492 Copy citation Copy BibTeX PLoS ONE 2012-02-16 Studerus E, Gamma A, Kometer M, Vollenweider FX. Europe PMC Published psilocybin AnxietyPersonality ChangeEmotional Processing Other More
Select for export Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-011-2358-5 PubMed 21674151 Copy citation Copy BibTeX Psychopharmacology 2011-06-14 Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. Europe PMC Published psilocybin AnxietySpiritualityMystical Experience Clinical Trial More
